Assignee
INOTEK PHARMACEUTICALS CORP
US·24 granted patents·20 pending applications·291 citations·filing 2001–2016
Top patents by PatentIndex Score
44 records- 0193US7268143B2Isoquinoline derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2004·Granted Sep 11, 2007·61 cites·5 claims
- 0292US7423144B2Purine Derivatives as adenosine A1 receptor agonists and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2005·Granted Sep 9, 2008·18 cites·43 claims
- 0390US7642250B2N-benzyl substituted pyridyl porphyrin compounds and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2006·Granted Jan 5, 2010·19 cites·22 claims
- 0490US6828319B2Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2002·Granted Dec 7, 2004·34 cites·131 claims
- 0589US7732424B2Purine derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2006·Granted Jun 8, 2010·13 cites·35 claims
- 0688US6534651B27-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2001·Granted Mar 18, 2003·29 cites·18 claims
- 0787US7381722B2Tetracyclic amino and carboxamido compounds and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2006·Granted Jun 3, 2008·9 cites·29 claims
- 0887US6903079B2Nucleoside compounds and compositions thereofINOTEK PHARMACEUTICALS CORP·Filed 2002·Granted Jun 7, 2005·23 cites·12 claims
- 0986US8895530B2Method of reducing intraocular pressure in humansINOTEK PHARMACEUTICALS CORP·Filed 2013·Granted Nov 25, 2014·7 cites·20 claims
- 1086US6956035B2Isoquinoline derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2003·Granted Oct 18, 2005·19 cites·22 claims
- 1185US7217709B2Tetracyclic benzamide derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2004·Granted May 15, 2007·19 cites·15 claims
- 1283US9522160B2Ophthalmic formulationsINOTEK PHARMACEUTICALS CORP·Filed 2014·Granted Dec 20, 2016·2 cites·13 claims
- 1383US9289383B2Method of reducing intraocular pressure in humansINOTEK PHARMACEUTICALS CORP·Filed 2014·Granted Mar 22, 2016·4 cites·28 claims
- 1481US7393955B2Isoquinoline derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2005·Granted Jul 1, 2008·5 cites·3 claims
- 1580US7863253B2Purine Derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2005·Granted Jan 4, 2011·3 cites·10 claims
- 1680US7652028B2Indenoisoquinolinone analogs and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2006·Granted Jan 26, 2010·6 cites·28 claims
- 1778US7432369B2Pyridyl-substituted porphyrin compounds and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2005·Granted Oct 7, 2008·3 cites·19 claims
- 1875US9278991B2Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereofINOTEK PHARMACEUTICALS CORP·Filed 2013·Granted Mar 8, 2016·2 cites·26 claims
- 1972US7078423B25-Aryltetrazole compounds, compositions thereof, and uses thereforINOTEK PHARMACEUTICALS CORP·Filed 2002·Granted Jul 18, 2006·6 cites·50 claims
- 2070US9370530B2Combination, kit and method of reducing intraocular pressureINOTEK PHARMACEUTICALS CORP·Filed 2014·Granted Jun 21, 2016·1 cites·25 claims
- 2168US7087631B2Aryltetrazole compounds, and compositions thereofINOTEK PHARMACEUTICALS CORP·Filed 2003·Granted Aug 8, 2006·3 cites·5 claims
- 2267US6958324B2Inosine compounds and their use for treating or preventing an inflamation or a reperfusion diseaseINOTEK PHARMACEUTICALS CORP·Filed 2002·Granted Oct 25, 2005·5 cites·29 claims
- 2360US2017049799A1Ophthalmic formulationsINOTEK PHARMACEUTICALS CORP·Filed 2016·Application pending·0 cites
- 2460US2010113386A1N-benzyl substituted pyridyl porphyrin compounds and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 2559US2008262016A1Isoquinoline derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2008·Application pending·0 cites
- 2657US2010179140A1Indenoisoquinolinone analogs and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 2755US2008009473A1Pyridyl-substituted porphyrin compounds and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2007·Application pending·0 cites
- 2853US2016158268A1Method of reducing intraocular pressure in humansINOTEK PHARMACEUTICALS CORP·Filed 2016·Application pending·0 cites
- 2951US7135491B25-Aryltetrazole compounds and uses thereofINOTEK PHARMACEUTICALS CORP·Filed 2005·Granted Nov 14, 2006·0 cites·13 claims
- 3051US2010261706A1Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereofINOTEK PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 3151US2007249653A1Tetracyclic benzamide derivatives and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2007·Application pending·0 cites
- 3251US2017151273A1Ophthalmic formulationsINOTEK PHARMACEUTICALS CORP·Filed 2016·Application pending·0 cites
- 3351US2009257999A1Method of preventing contrast-induced nephropathyINOTEK PHARMACEUTICALS CORP·Filed 2008·Application pending·0 cites
- 3449US9718853B2Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-YL)-3,4-dihydroxytetrahydrofuran-2-YL)] methyl nitrate and processes of preparation thereofINOTEK PHARMACEUTICALS CORP·Filed 2016·Granted Aug 1, 2017·0 cites·18 claims
- 3549US2013217643A1Method of reducing intraocular pressure in humansINOTEK PHARMACEUTICALS CORP·Filed 2013·Application pending·0 cites
- 3649US2016367586A1Combination, kit and method of reducing intraocular pressureINOTEK PHARMACEUTICALS CORP·Filed 2016·Application pending·0 cites
- 3747US2007238694A1Purine compounds and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2007·Application pending·0 cites
- 3844US2006287313A1Isoquinoline compounds and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 3944US2014275128A1Method of providing ocular neuroprotectionINOTEK PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 4044US2006287311A1Tetracyclic Sulfonamide Compounds and methods of use thereofINOTEK PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 4138US2002164633A1Cell-based assay for detecting activation of poly (ADP-ribose) polymeraseINOTEK PHARMACEUTICALS CORP·Filed 2002·Application pending·0 cites
- 4236US2016158267A1Methods of preventing, reducing or treating macular degenerationINOTEK PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 4332US2011123622A1Ophthalmic formulation and method of manufacture thereofINOTEK PHARMACEUTICALS CORP·Filed 2010·Application pending·0 cites
- 4432US2010239583A1Antibodies against flagellin and uses thereofINOTEK PHARMACEUTICALS CORP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INOTEK PHARMACEUTICALS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →